Gut Microbiota
A section of Microorganisms (ISSN 2076-2607).
Section Information
The symbiosis between the gut microbiota and the host depends on the metabolic and immunologic interaction with the host. Over the last ten years it has become evident that the development of a dysbiosis plays an important role in many diseases. These include metabolisms related diseases such as the metabolic syndrome, and diseases of the intestinal tract such as inflammatory bowel diseases, but there is also a gut–brain–axis that can be influenced by the intestinal microbiota.
With the advent of metagenomics, the question of the composition became addressable and associations between the development of a dysbiosis and an altered composition of the microbiota can now be analyzed. Given the extremely broad range of metabolic functions in the hundreds of species, a mechanistic understanding is key to detect the actual functionalities of the different families and species in the consortia.
In the section Gut Microbiota, we will focus on research questions aiming at the microbial ecology in the community, the functionalities of members of the microbiota, the metabolic and immunological interaction with the host and the role of the microbiota in human diseases. The editorial board will review all manuscripts submitted for publication in this section. However, articles which seem to be outside the scope of the subject matter listed here may be referred to another section of Microorganisms.
Keywords
• Microbial community genetics, transcriptomics, proteomics and metabolomics
• Interaction within the microbiota
• Metabolic interaction with the host
• Inflammatory diseases
• Interaction with the immune system
• Microbial biodegradation of nutrients and xenobiotics
• Microbial ecology
• Microbial functions in the different habitats within the gut
• Metabolic flux analysis
• Analysis of functionalities by stable isotope probing (DNA, RNA and protein)
• Model systems for studying microbiome biology
• Novel technologies for the analysis of structure and function of the microbiota
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Beneficial Microbes and Gastrointestinal Microbiota 2.0 (Deadline: 31 March 2024)
- Intestinal Dysbiosis (Deadline: 31 March 2024)
- State-of-the-Art of Gut Microbiota in Italy (2023, 2024) (Deadline: 31 March 2024)
- Effects of Gut Microbiota on Human Health and Disease (Deadline: 30 April 2024)
- Nutritional Regulation on Gut Microbiota, 2nd Edition (Deadline: 30 April 2024)
- The Impact of Probiotics on Gut Health (Deadline: 30 April 2024)
- Intestine as a Hub for Host-Microbe Interactions and Its Impact on Local and Systemic Health (Deadline: 30 April 2024)
- Gut Microbiota and Nutrients 2.0 (Deadline: 15 May 2024)
- Gut Microbiota and Precise Modulation (Deadline: 15 June 2024)
- Interplay between Gut Microbiota and Antimicrobial Resistance (Deadline: 15 June 2024)
- Probiotics: The Current State of Scientific Knowledge (Deadline: 30 June 2024)
- The Role of the Gut Microbiome in Bacteria and Virus Infections (Deadline: 30 June 2024)
- Gut Microbiota, Zoonotic Diseases and Antimicrobial Research (Deadline: 30 June 2024)
- Latest Review Papers in Gut Microbiota 2024 (Deadline: 15 July 2024)
- Novel Strategies in the Study of the Human Gut Microbiota 2.0 (Deadline: 15 July 2024)
- The Role of Gut Microbiota in Inflammatory Bowel Disease: Mechanisms and Novel Therapeutic Approaches (Deadline: 15 July 2024)
- Gut Microbiota: Metagenomics to Study Ecology (Deadline: 31 July 2024)
- Enteric Disease-Associated Pathogens (Deadline: 31 July 2024)
- Gut Microbiota in Disease—Third Edition (Deadline: 31 July 2024)
- Bioactive Substances, Gut Microbiome, and Host Health (Deadline: 31 July 2024)
- Gut Microbiome in Homeostasis and Disease 2.0 (Deadline: 31 July 2024)
Topical Collection
Following topical collection within this section is currently open for submissions: